Envista Holdings (NVST) Interest & Investment Income (2023 - 2026)
Envista Holdings (NVST) recorded quarterly Interest & Investment Income of -$7.4 million in Q2 2026, up 28.16% quarter-over-quarter from -$10.3 million in Q4 2025, and up 20.43% on a YoY basis from -$6.1 million in Q2 2025.
Envista Holdings (NVST) Interest & Investment Income (2023 - 2026) Analysis & Trends
Envista Holdings' Interest & Investment Income history runs 4 years deep, the most recent figure standing at -$7.4 million for Q2 2026.
- In Q2 2026, Interest & Investment Income rose 20.43% year-over-year to -$7.4 million; the TTM figure through Apr 2026 stood at -$34.7 million (up 18.93% YoY), while the FY2025 annual figure was -$36.6 million, up 21.12% from the prior year.
- Interest & Investment Income was -$7.4 million for Q2 2026 at Envista Holdings, up from -$10.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$7.4 million in Q2 2026 to a low of -$15.4 million in Q3 2023.
- Historically, Interest & Investment Income has averaged -$10.9 million across 4 years, with a median of -$10.3 million in 2025.
- Biggest YoY gain for Interest & Investment Income was 31.62% in 2025; the steepest drop was 4.04% in 2025.
- A 4-year view of Interest & Investment Income shows it stood at -$13.9 million in 2023, then climbed by 28.78% to -$9.9 million in 2024, then fell by 4.04% to -$10.3 million in 2025, then rose by 28.16% to -$7.4 million in 2026.
- The last three Interest & Investment Income figures came in at -$7.4 million (Q2 2026), -$10.3 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 147.79 Bn | 143.40 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.23 Bn | 40.22 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.57 Bn | 36.41 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.04 Bn | 26.38 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.76 Bn | 23.24 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.40 Bn | 13.40 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.18 Bn | 13.04 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.71 Bn | 8.67 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Envista Holdings | 4.04 Bn | 2.96 Bn | 390.10 Mn | -7.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -7.40 Mn |
| Dec 31, 2025 | -10.30 Mn |
| Sep 26, 2025 | -9.00 Mn |
| Jun 27, 2025 | -8.00 Mn |
| Mar 28, 2025 | -9.30 Mn |
| Dec 31, 2024 | -9.90 Mn |
| Sep 27, 2024 | -11.90 Mn |
| Jun 28, 2024 | -11.70 Mn |
| Mar 29, 2024 | -12.90 Mn |
| Dec 31, 2023 | -13.90 Mn |
| Sep 29, 2023 | -15.40 Mn |